Literature DB >> 8390609

Analysis of anticholinesterase-induced neuromuscular transmission failure.

R A Maselli1, C Leung.   

Abstract

To define the underlying mechanism of neuromuscular transmission failure induced by anticholinesterases, we simultaneously performed surface recordings of compound muscle action potentials (CMAPs) and intracellular recordings of miniature end-plate potentials (MEPPs), miniature end-plate current (MEPCs), and end-plate potential (EPPs) in rat diaphragms exposed in vitro to 1 x 10(-4) to 2 x 10(-2) mmol/L neostigmine methylsulfate. At low concentrations of neostigmine, repetitive stimulation of the phrenic nerve resulted in decrement followed by complete recuperation of CMAP amplitudes. This bimodal pattern was associated with maximal end-plate depolarization at the beginning of the stimulation period, increased MEPP amplitudes, and prolonged time constants of MEPC decays. Higher concentrations of neostigmine resulted in a unimodal decline of amplitudes of CMAPs and EPPS, reduced MEPP amplitudes, and a double exponential time course of MEPC decays. These results indicate that low concentrations of anticholinesterases impaired neuromuscular transmission by producing transient depolarization of the end-plate region. Higher concentrations induced desensitization and direct blockade of the end-plate receptor channel, probably in its open conformation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390609     DOI: 10.1002/mus.880160518

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  6 in total

Review 1.  Neuromuscular transmission and its pharmacological blockade. Part 3: Continuous infusion of relaxants and reversal and monitoring of relaxation.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

2.  Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms.

Authors:  Christopher M Gomez; Ricardo A Maselli; Bhupinder P S Vohra; Manuel Navedo; Joel R Stiles; Pierre Charnet; Kelly Schott; Legier Rojas; John Keesey; Anthony Verity; Robert W Wollmann; Jose Lasalde-Dominicci
Journal:  Ann Neurol       Date:  2002-01       Impact factor: 10.422

3.  Defective fast inactivation recovery of Nav 1.4 in congenital myasthenic syndrome.

Authors:  W David Arnold; Daniel H Feldman; Sandra Ramirez; Liuyuan He; Darine Kassar; Adam Quick; Tara L Klassen; Marian Lara; Joanna Nguyen; John T Kissel; Christoph Lossin; Ricardo A Maselli
Journal:  Ann Neurol       Date:  2015-03-27       Impact factor: 10.422

4.  Bispyridinium Compounds Inhibit Both Muscle and Neuronal Nicotinic Acetylcholine Receptors in Human Cell Lines.

Authors:  Avi Ring; Bjorn Oddvar Strom; Simon R Turner; Christopher M Timperley; Michael Bird; A Christopher Green; John E Chad; Franz Worek; John E H Tattersall
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

5.  The spectrum of intermediate syndrome following acute organophosphate poisoning: a prospective cohort study from Sri Lanka.

Authors:  Pradeepa Jayawardane; Andrew H Dawson; Vajira Weerasinghe; Lakshman Karalliedde; Nicholas A Buckley; Nimal Senanayake
Journal:  PLoS Med       Date:  2008-07-15       Impact factor: 11.069

6.  Balanced modulation of neuromuscular synaptic transmission via M1 and M2 muscarinic receptors during inhibition of cholinesterases.

Authors:  Oksana A Lenina; Konstantin A Petrov
Journal:  Sci Rep       Date:  2022-02-01       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.